Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 29.65
0.00 (0.00%)
Jul 30, 2026, 9:59 AM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.09 billion as of July 29, 2026. Its market cap has increased by 18.60% in one year.
Market Cap
1.09B
Enterprise Value
1.35B
Revenue
1.06B
Ranking
n/a
PE Ratio
11.36
Stock Price
29.65
ChartMarket Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.09B, a decrease of -44.16%. That is a compound annual growth rate of -16.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.09B | -4.66% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.92B |
| InnoPharmax | 1.27B |
| GeneFerm Biotechnology | 1.17B |
| Excelsior Biopharma | 1.13B |
| DV Biomed | 973.97M |
| Winston Medical Supply | 944.79M |
| Anxo Pharmaceutical | 899.52M |
| Original BioMedicals | 819.04M |